Gabapentin

Failed to add items

Sorry, we are unable to add the item because your shopping cart is already at capacity.

Add to basket failed.

Please try again later

Add to wishlist failed.

Please try again later

Remove from wishlist failed.

Please try again later

Adding to library failed

Please try again

Follow podcast failed

Unfollow podcast failed

Gabapentin

Listen for free

View show details

Gabapentin has become a go-to option across a wide range of clinical scenarios—but how well does it actually hold up under closer scrutiny?In this episode, Don Weinberger and Steve Small take a closer look at how gabapentin performs in real-world use—and where expectations may not match the data.🧠Does gabapentin meaningfully improve neuropathic pain outcomes—or are we overestimating its impact in everyday practice?⚠️ How should clinicians interpret safety concerns like dependence, cognitive effects, and mood changes when counseling patients?🔍 Are we using gabapentin for the right types of pain—or defaulting to it when evidence is limited?We’ll break down the data, challenge common assumptions, and follow the evidence wherever it leads—so you can separate clinical signal from background noise when evaluating gabapentin.Key claims explored in this episode include:Gabapentin is modestly effective for neuropathic painGabapentin is addictiveGabapentin causes dementiaGabapentin is associated with suicidal behaviorYou’ll also get quick clinical insights on:Cardiovascular risk signals linked to gabapentin useWhether gabapentin plays a role in treating anxiety disorders🏷️ Our listeners can get 10% off a new or upgraded subscription with code rvt1026 at checkout. ******TRC Healthcare Editor Hosts:Stephen Small, PharmD, BCPS, BCPPS, BCCCP, CNSC Don Weinberger, PharmD, PMSP******Guest: Adam Kaye, PharmD, FASCP, FCPhA******CE Information:None of the speakers have anything to disclose. TRC Healthcare offers CE credit for this podcast for subscribers at our platinum level or higher. Log in to your Pharmacist’s Letter, Pharmacy Technician’s Letter,or Prescriber Insights account and look for the title of this podcast in the list of available CE courses.Claim Credit******The clinical resources mentioned during the podcast are part of a subscription to Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights: Chart: Pharmacotherapy of Neuropathic PainFAQ: Treating FibromyalgiaCE: Controlled Substance Prescription ValidationChart: Potentially Harmful Drugs: Beers CriteriaAlgorithm: Treatment of HypertensionChart: Pharmacotherapy of Anxiety Disorders******Suicide & Crisis Lifeline - Call or Text: 988https://988lifeline.org/******Don’t miss out! Subscribe today to stay ahead with trusted insights and tools. 🎓 If you're a student, good news—students can access a free version of Pharmacist’s Letter. ******Rumor vs Truth is a production of TRC Healthcare.Send us Fan MailEmail us: rumorvstruth@trchealthcare.comThe content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment.Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here.Learn more about our product offerings at trchealthcare.com.

No reviews yet